Piedmont Healthcare Atlanta

Atlanta, Georgia 30318

3 studies enrolling now · 4 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Limited Stage Small Cell Lung Cancer, Progressive Pulmonary Fibrosis

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS) — Recruiting now
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis — Completed